Griffin Centre Mental Health Services

griffincentre.org

Griffin Centre is an accredited non-profit mental health agency providing flexible and accessible services to youth, adults and their families. Since 1975, Griffin Centre has been delivering services to people who thought their needs didn't count. We continue to expand our programs and services to respond to the changing and emerging needs of diverse individuals in our community. We help them find solutions to their challenges. We help over 2,500 people each year to recognize their strengths, achieve their goals and improve their lives.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

BIONTECH AND MEDIGENE ANNOUNCE GLOBAL COLLABORATION TO ADVANCE T CELL RECEPTOR IMMUNOTHERAPIES AGAINST CANCER

BioNTech SE | February 22, 2022

news image

BioNTech SE and Medigene AG a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. The initial term of the collaboration is three years. Medigene will contribute its proprietary TCR discovery platform for the development of TCRs against multiple solid tumor targets nominated by BioNTech. Medigene&rsqu...

Read More

Cell and Gene Therapy

BIOCENTRIQ® AND KYTOPEN® EXPAND PARTNERSHIP TO EXPEDITE IMPACT OF TRANSFORMATIVE GENE-EDITING TECHNOLOGY ON CELL THERAPY MANUFACTURING

PRNewswire | June 12, 2023

news image

BioCentriq®, a strategic CDMO specializing in cell therapy announced that it has expanded its partnership with Kytopen, a Cambridge based startup spun out of Massachusetts Institute of Technology (MIT). The partnership was originally announced in March of 2021. In the initial phase of the collaboration, the Kytopen and BioCentriq teams worked together to test transfection of T-cells using Kytopen's Flowfect® technology and the potential impact to both autologous and ...

Read More

Industrial Impact

THERMO FISHER SCIENTIFIC’S LARGEST SINGLE-USE TECHNOLOGY MANUFACTURING SITE OPENS IN GREATER NASHVILLE

Thermo Fisher Scientific Inc. | August 23, 2022

news image

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-square-foot facility enables the company to help meet rapidly growing demand for the bioprocessing materials needed to produce vaccines and breakthrough therapies for cancer and other diseases. This new site is part of Thermo Fisher’s $650 million multi-year investment to expand its bioprocessing production cap...

Read More

Medical

MINDMED ANNOUNCES THE START OF THE FIRST EVER CLINICAL TRIAL MEASURING AND EVALUATING MDMA AND LSD

MindMed | January 21, 2021

news image

MindMed, a main psychedelic medication biotech organization, reported today the beginning of the principal ever clinical preliminary estimating and assessing MDMA and LSD utilized in mix in the human body. The preliminary will be directed at the University Hospital Basel Liechti Lab, in Basel, Switzerland. If administered in combination with LSD, MDMA may expand positive abstract medication impacts, including positive state of mood and empathy, and lessen the negative feelings and...

Read More
news image

Industrial Impact

BIONTECH AND MEDIGENE ANNOUNCE GLOBAL COLLABORATION TO ADVANCE T CELL RECEPTOR IMMUNOTHERAPIES AGAINST CANCER

BioNTech SE | February 22, 2022

BioNTech SE and Medigene AG a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. The initial term of the collaboration is three years. Medigene will contribute its proprietary TCR discovery platform for the development of TCRs against multiple solid tumor targets nominated by BioNTech. Medigene&rsqu...

Read More
news image

Cell and Gene Therapy

BIOCENTRIQ® AND KYTOPEN® EXPAND PARTNERSHIP TO EXPEDITE IMPACT OF TRANSFORMATIVE GENE-EDITING TECHNOLOGY ON CELL THERAPY MANUFACTURING

PRNewswire | June 12, 2023

BioCentriq®, a strategic CDMO specializing in cell therapy announced that it has expanded its partnership with Kytopen, a Cambridge based startup spun out of Massachusetts Institute of Technology (MIT). The partnership was originally announced in March of 2021. In the initial phase of the collaboration, the Kytopen and BioCentriq teams worked together to test transfection of T-cells using Kytopen's Flowfect® technology and the potential impact to both autologous and ...

Read More
news image

Industrial Impact

THERMO FISHER SCIENTIFIC’S LARGEST SINGLE-USE TECHNOLOGY MANUFACTURING SITE OPENS IN GREATER NASHVILLE

Thermo Fisher Scientific Inc. | August 23, 2022

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-square-foot facility enables the company to help meet rapidly growing demand for the bioprocessing materials needed to produce vaccines and breakthrough therapies for cancer and other diseases. This new site is part of Thermo Fisher’s $650 million multi-year investment to expand its bioprocessing production cap...

Read More
news image

Medical

MINDMED ANNOUNCES THE START OF THE FIRST EVER CLINICAL TRIAL MEASURING AND EVALUATING MDMA AND LSD

MindMed | January 21, 2021

MindMed, a main psychedelic medication biotech organization, reported today the beginning of the principal ever clinical preliminary estimating and assessing MDMA and LSD utilized in mix in the human body. The preliminary will be directed at the University Hospital Basel Liechti Lab, in Basel, Switzerland. If administered in combination with LSD, MDMA may expand positive abstract medication impacts, including positive state of mood and empathy, and lessen the negative feelings and...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us